Key result
Wenyang Zhenshuai granules attenuate doxorubicin-induced cardiotoxicity and apoptosis by suppressing SERPINE1 expression in rats.
Why the study?
The cardioprotective effects and underlying molecular mechanisms of Wenyang Zhenshuai granules against doxorubicin-induced cardiotoxicity remained to be investigated.
Does Wenyang Zhenshuai granules (WYZSG) improve doxorubicin-induced cardiotoxicity in a rat model?
Does Wenyang Zhenshuai granules (WYZSG) improve doxorubicin-induced cardiotoxicity in a rat model?
WYZSG attenuates doxorubicin-induced cardiotoxicity in rats by suppressing SERPINE1 expression, providing mechanistic insight into its cardioprotective effects.
Answers are grounded in this paper and cite their sources.
Does not yet support clinical use; extends mechanistic insight into SERPINE1 as a doxorubicin cardiotoxicity target.
Objective To investigate the cardioprotective effects of Wenyang Zhenshuai granules (WYZSG) against doxorubicin (DOX)-induced cardiotoxicity and elucidate the underlying molecular mechanisms. Methods Network pharmacology was performed to identify the potential therapeutic targets of WYZSG against doxorubicin (DOX)-induced cardiac injury. Protein–protein interaction (PPI) network construction, hub gene analysis, and molecular docking were conducted to identify key targets and validate the interactions between the major active compounds and core targets. In vivo, a rat model of DOX-induced cardiac injury was established to evaluate the effects of WYZSG on cardiac injury, histopathological changes, apoptosis, and serpin family E member 1 (SERPINE1) expression. The role of SERPINE1 in the protective effects of WYZSG was further validated through SERPINE1 overexpression experiments. Results A total of 65 bioactive compounds and 1,057 putative targets were identified, with 49 overlapping targets associated with cardiac injury. Network analysis highlighted genistein, L-phenylalanine, daidzein, nobiletin, and isoliquiritigenin as the major active constituents, while SERPINE1 emerged as a central hub gene. Molecular docking confirmed strong binding affinities between these core compounds and SERPINE1. In vivo, WYZSG attenuated DOX-induced cardiac injury, reduced serum creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH) levels, alleviated myocardial histopathological damage, inhibited cardiomyocyte apoptosis, and dose-dependently downregulated SERPINE1 expression in DOX-treated rats. Notably, SERPINE1 overexpression partially abolished the cardioprotective effects of WYZSG against DOX-induced cardiac injury. Conclusion WYZSG protects against DOX-induced cardiac injury by suppressing SERPINE1 expression, providing mechanistic insight into its cardioprotective effects and supporting its potential therapeutic application in DOX-induced cardiac injury.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2026) studied Doxorubicin-induced cardiotoxicity (n=48). Wenyang Zhenshuai granules (WYZSG) vs. Doxorubicin alone was evaluated on Cardiac injury and SERPINE1 expression. Wenyang Zhenshuai granules dose-dependently attenuated doxorubicin-induced cardiac injury, reduced myocardial apoptosis, and improved cardiac function in rats by suppressing SERPINE1 expression.
Synapse has enriched 10 related papers. Consider them for comparative context: